Glucophage XR Shortage Update: What Patients Need to Know in 2026

If you've been struggling to fill your metformin extended-release prescription — whether it's labeled as Glucophage XR, metformin ER, or just "metformin extended release" — you may be wondering: is there still a shortage? What's the current situation? And what can you do to make sure you don't miss doses of this critical diabetes medication?

Here's everything you need to know about Glucophage XR availability as of 2026, along with practical steps to protect your medication access.

Current Status: Is Glucophage XR in Shortage in 2026?

As of 2026, there is no active FDA-listed national shortage of generic metformin extended-release (Glucophage XR). The FDA's drug shortage database does not flag metformin ER as being in shortage. The worst of the supply disruptions — which stemmed primarily from the 2020 NDMA recall — have largely resolved.

However, this doesn't mean every pharmacy has every strength on every shelf. Individual pharmacies can be out of stock temporarily based on their supply chain, local demand, or ordering patterns. The absence of a national shortage doesn't guarantee your specific pharmacy has the 750 mg XR tablets you need today.

A Brief History of Glucophage XR Supply Issues

To understand where things stand today, it helps to know what happened over the past several years:

• 2000: Glucophage XR 500 mg approved by the FDA; launches in the U.S. market
• May 2020: FDA finds NDMA contamination in some extended-release metformin products; recalls affect multiple generic manufacturers. Patients on recalled formulations scramble to find alternatives, creating supply pressure across the entire metformin ER market.
• 2021-2022: Market gradually recovers as manufacturers reformulate products and new generic manufacturers receive FDA approval for metformin ER.
• 2023-2024: The original brand-name Glucophage XR is discontinued. Generics from multiple manufacturers are the standard. Supply is generally stable but with occasional localized gaps.
• 2025-2026: No national shortage. Generic metformin ER is available from multiple manufacturers. Patients may still encounter occasional localized stockouts, but these are typically resolved quickly.

Why Some Patients Still Run Into Problems

Even without a national shortage, patients can still run into pharmacy-level availability issues. The most common reasons:

• Your pharmacy may stock one strength (e.g., 500 mg) but not another (750 mg or 1000 mg)
• A specific generic manufacturer's product may be backordered, even if other manufacturers' versions are available
• Smaller independent pharmacies may have longer reorder cycles
• Demand is high — with millions of Americans using metformin ER, any supply disruption ripples quickly

What to Do If Your Pharmacy Is Out of Stock

Here's a proven action plan if you can't fill your Glucophage XR prescription:

1. Use medfinder: Visit medfinder.com to have pharmacies in your area checked for current stock of your medication. You'll get results texted to you.
2. Call your doctor immediately: Don't let a pharmacy stockout become a dangerous gap in your diabetes management. Your doctor can help bridge you with immediate-release metformin or adjust your treatment plan.
3. Try a different pharmacy type: Independent pharmacies often source from different wholesalers than chains. Warehouse clubs (Costco, Sam's Club) are also worth checking.
4. Ask about equivalent generics: Different manufacturers make metformin ER. If one manufacturer's product is unavailable, your pharmacy may be able to order from a different manufacturer.
5. Consider mail-order: For a maintenance medication like metformin ER, mail-order pharmacies often have reliable supply of generics and may offer 90-day fills at a lower cost.

Should You Be Worried About Future Shortages?

The 2020 NDMA recall was a major disruption, but the metformin ER market has since diversified its manufacturing base. As of 2026, there are multiple FDA-approved generic manufacturers producing metformin ER tablets, which provides more resilience against future supply shocks. That said, the pharmaceutical supply chain is always subject to disruption — manufacturing issues, raw material shortages, and regulatory actions can happen unexpectedly.

The best protection is to always have a buffer supply and to have a backup plan (like knowing you can switch to IR metformin) ready in case of future supply issues.

The Bottom Line

As of 2026, Glucophage XR (metformin ER) is not in an active national shortage. However, pharmacy-level availability issues are real and can affect individual patients. The key is having a plan: use medfinder to find nearby pharmacies with stock, refill early, and know your backup options. See our guide to alternatives to Glucophage XR if you need additional options to discuss with your doctor.